BSAC Vanguard Series: the future of ADVOCACY on AMR

Volume: 77, Issue: 1, Pages: 1 - 2
Published: Nov 18, 2021
Abstract
The COVID public health emergency has brought home how vulnerable we are to forces beyond our control. We are losing our ability to treat infectious diseases for a number of reasons, including antimicrobial resistance (AMR). AMR is a 'slow-moving' threat, which makes it harder to recognize and address. The situation has not been helped by the difficulty we have had in seeing the actions and health of everyone on this planet as interconnected....
Paper Details
Title
BSAC Vanguard Series: the future of ADVOCACY on AMR
Published Date
Nov 18, 2021
Volume
77
Issue
1
Pages
1 - 2
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.